Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Medchemexpress/AP20187/HY-13992/50mg188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Medchemexpress/AP20187/HY-13992/50mg

AP20187isacell-permeablemoleculeusedtodimerizeFK506-bindingprotein(FKBP)fusionproteinsandinitiateBIOLOGicalsignalingcascadesandgeneexpressionordisruptprotein-proteininteractions.
Description

AP20187isacell-permeablemoleculeusedtodimerizeFK506-bindingprotein(FKBP)fusionproteinsandinitiatebiologicalsignalingcascadesandgeneexpressionordisruptprotein-proteininteractions.

IC50&Target

FKBPhomodimerizer[1]

InVitro

WhenLNCaPcellsaretreatedwithAP20187(100nM),ro-iCaspase-9levelsaresignificantlyreduced,andthesmallerprocessedactivecaspase-9becomesapparent[2].

InVivo

Real-timePCRanalysisshowsthatAP20187(0.5mg/kg,2mg/kg,or5mg/kg)treatmentsignificantlyincreasesthelevelsofCHOPmRNAintheCNSofPLP/Fv2E-PERKmiceatPID12.AP20187treatmentsignificantlyalleviatesEAE-inducedmyelindamageinthesemice.AP20187treatmentsignificantlyreducesthenumberofdegeneratingaxonsandincreasesthedensityofaxonsinthedemyelinatinglesionsinthelumbarspinalcordofPLP/Fv2E-PERKmice[2].

References
  • [1].AhmedS,etal.PhotocleavabledimerizerfortherapidreversalofmoleculartrapantagoNISTs.JBiolChem.2014Feb21;289(8):4546-52.

    [2].LinW,etal.Oligodendrocyte-specificactivationofPERKsignalingprotectsmiceagainstexperimentalautoimmuneencephalomyelitis.JNeurosci.2013Apr3;33(14):5980-91.

    [3].HaasME,etal.TheRoleofProproteinConvertaseSubtilisin/KexinType9inNephroticSyndrome-AssociatedHypercholesterolemia.Circulation.2016Jul5;134(1):61-72.

PreparingStockSolutions
ConcentrationVolumeMass1mg5mg10mg
1mM0.6744mL3.3721mL6.7442mL
5mM0.1349mL0.6744mL1.3488mL
10mM0.0674mL0.3372mL0.6744mL
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.
CellAssay
[2]

AP20187isdissolvedinPBS[2].

Fortheinvitrostudy,16hafterADVinfection,cellsaretreatedwithR1881(10nM),AP20187(10nM),both,orneitherfor8h.CellsarethenrinsedwithPBSandfixedwith4%paraformaldehydefor1hatroomtemperature.AfterrinsingwithPBS,cellsareincubatedinice-coldpermeABIlizationsolution(0.1%TritonX-100,0.1%sodiumcitrate)for2minat0°C.CellsarerinsedwithPBSandstainedwithTUNELreactionmixturefor60minat37°C.AfteranotherPBSwash,cellsareincubatedwithConverter-APfor30minat37°C.Cellsarerinsedandincubatedwithsubstrate5-bromo-4-chloro-3-indolylphosphate/nitrobluetetrazoliumfor30min.AfterafinalPBSrinse(repeatedtwice),cellsaremicrophotographed[2].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

AnimalAdministration
[2]

AP20187isdissolvedin100%ethanolataconcentrationof62.5mg/mLandstored(20°C).Thentreatmentsolutionsisfreshlypreparedfromadilutionof1.25mg/mLconsistingof4%ethanol,10%PEG-400,and2%Tween-20inwater[2].

Mice[2]
ToactivatethetransgeneFv2E-PERKinoligodendrocytes,PLP/Fv2E-PERKtransgenicmicearegivenintraperitonealinjectionsofAP20187dailyatadoseof0.5mg/kg,2mg/kg,or5mg/kg.LyophilizedAP20187isdissolvedin100%ethanolataconcentrationof62.5mg/mLstocksolutionandstoredat−20°C.Injectionsolutionsconsistof4%ethanol,10%PEG-400,and2%Tween-20inwater.Thetransgenicmicereceivingonlythevehicle(4%ethanol,10%PEG-400,2%Tween-20inwater)servedascontrols.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References
  • [1].AhmedS,etal.Photocleavabledimerizerfortherapidreversalofmoleculartrapantagonists.JBiolChem.2014Feb21;289(8):4546-52.

    [2].LinW,etal.Oligodendrocyte-specificactivationofPERKsignalingprotectsmiceagainstexperimentalautoimmuneencephalomyelitis.JNeurosci.2013Apr3;33(14):5980-91.

    [3].HaasME,etal.TheRoleofProproteinConvertaseSubtilisin/KexinType9inNephroticSyndrome-AssociatedHypercholesterolemia.Circulation.2016Jul5;134(1):61-72.

MolecularWeight

1482.75

Formula

C₈₂H₁₀₇N₅O₂₀

CASNo.

195514-80-8

Storage
Powder-20°C3years
 4°C2years
Insolvent-80°C6months
 -20°C1month
Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

DMSO:≥57mg/mL

AP20187isdissolvedin4%ethanol,10%PEG-400,1.75%Tween-20inH2O[3].

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

References
  • [1].AhmedS,etal.Photocleavabledimerizerfortherapidreversalofmoleculartrapantagonists.JBiolChem.2014Feb21;289(8):4546-52.

    [2].LinW,etal.Oligodendrocyte-specificactivationofPERKsignalingprotectsmiceagainstexperimentalautoimmuneencephalomyelitis.JNeurosci.2013Apr3;33(14):5980-91.

    [3].HaasME,etal.TheRoleofProproteinConvertaseSubtilisin/KexinType9inNephroticSyndrome-AssociatedHypercholesterolemia.Circulation.2016Jul5;134(1):61-72.

Purity:99.80%

新闻动态
行业前沿
技术文章
最新产品